A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen.
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 19 - Any |
| Updated: | 10/7/2018 |
| Start Date: | April 11, 2018 |
| End Date: | December 31, 2025 |
A Retrospective and Prospective Study of a New Immunotherapy Regimen (MyVaccx) for Patients With Adenocarcinoma.
A retrospective and prospective data collection study on 17 consecutive subjects with
adenocarcinoma who were treated using the MyVaccx system by Dr. Gary Onik. Retrospective data
was collected on the treatment with the immunotherapy system and prospective data will be
collected as they are prospectively monitored through their normal standard of care for their
original cancer.
adenocarcinoma who were treated using the MyVaccx system by Dr. Gary Onik. Retrospective data
was collected on the treatment with the immunotherapy system and prospective data will be
collected as they are prospectively monitored through their normal standard of care for their
original cancer.
Inclusion Criteria:
- Treatment with the MyVaccx System
- Greater than 18 years of age
- Signature of the informed consent
Exclusion Criteria:
- 2 subjects treated with the MyVaccx System with known visceral disease
We found this trial at
1
site
Click here to add this to my saved trials
